Funder
The Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia [J]. N Engl J Med. 2006;354(2):166–78.
2. Stanulla M, Schrappe M. Treatment of childhood acute lymphoblastic leukemia [J]. Semin Hematol. 2009;46(1):52–63.
3. Shurtleff SA, Buijs A, Behm FG, Rubnitz JE, Raimondi SC, Hancock ML, et al. TEL/AML1 fusion resulting from a cryptic t (12; 21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis [J]. Leukemia. 1995;9(12):1985–9.
4. Romana SP, Mauchauffé M, Le Coniat M, Chumakov I, Le Paslier D, Berger R, et al. The t (12; 21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion [J]. Blood. 1995;85(12):3662–70.
5. Borkhardt A, Cazzaniga G, Viehmann S, Valsecchi MG, Ludwig WD, Burci L, et al. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the berlin-Frankfurt-Munster study group [J]. Blood. 1997;90(2):571–7.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献